Parkinson's disease is a progressive, neurodegenerative brain disease. Parkinson's disease causes a part of the brain that is essential for movement, known as the substantia nigra, to degenerate.
News on Parkinson's
Follow Us On TwitterTweets by @BlechFoundation
The Blechman Foundation’s mission is to fund research to identify neuroprotective agents that provide disease-modifying effects in PD patients. This is the most promising way to slow or stop PD progression and prevent the development of intolerable disability. This report highlights developments in neuroprotective research in 2014. There are many challenges to delivering a neuroprotective… Read More
We are excited to announce that former major league baseball player Ben Petrick is supporting the Foundation’s efforts to fund neuroprotective research through promotions with MLB teams. Ben is among a few baseball players who have courageously and publicly acknowledged and discussed their PD. Ben’s life story is fantastic! The Colorado Rockies drafted Ben in… Read More
As PD progresses, patients must take increasingly large doses of medication to manage the escalating symptoms. These medications come with a heavy price, including the trademark tremors or muscle spasms most widely associated with the disease.
Who We Are
The inspiration behind our cause is our mother, who was diagnosed with Parkinson’s in 2008. On behalf of our mom and others like her, we are committed to hastening progress in the fight against the disease. Let's get started. More
The Blechman Foundation funds Parkinson's disease research primarily in the area of neuroprotection. More
The Foundation is proud to announce a grant for neuroprotective research to the Pittsburgh Institute for Neurodegenerative Diseases at the University of Pittsburgh. More
Subscribe to our mailing list.